en · de · es · fr · pt
epitalon-notes.peptides6908.com › Guide › Background And Chemical Identity — What the Evidence Shows

Background And Chemical Identity — What the Evidence Shows

By Editorial Desk · published 2026-07-10 · last reviewed 2026-08-01 · Guide

This is a working overview of AEDG, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.

Background and Chemical Identity

Several names circulate for the same molecule, including epitalon, epithalone, epithalamin tetrapeptide, and the sequence code AEDG. A CAS registry number, 307297-39-8, is commonly cited for it, though catalogue entries should be checked against supplier documentation because mislabelled records occur. In its usual form the peptide carries free amino and carboxyl termini and is neither glycosylated nor lipidated. Researchers distinguish the defined tetrapeptide from epithalamin itself, a crude pineal preparation containing many peptides that is not chemically characterised.

Material supplied for laboratory use is normally a lyophilised white to off-white powder that dissolves readily in water and in isotonic saline. Lyophilised cakes are hygroscopic and should be equilibrated to room temperature before opening to limit condensation on the solid. Solutions are typically prepared at milligram-per-millilitre concentrations and divided into single-use aliquots, because repeated freeze–thaw cycles degrade short peptides. Aqueous solutions are far less stable than the dry powder, and identity is usually verified by mass spectrometry alongside purity estimation from reversed-phase high-performance liquid chromatography.

Epitalon is a synthetic linear tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and the calculated mass is approximately 390.35 g/mol. The compound is made by solid-phase peptide synthesis rather than extracted from tissue, although early work described it as a short fragment of a peptide fraction obtained from bovine pineal extract. In the research literature the spelling epitalon and the variant epithalone both appear, while AEDG is the standard code used in peptide nomenclature.

Analytical Verification and Storage

No pharmacopoeial monograph exists for this peptide, so quality rests on the supplier's internal specifications and on whatever independent testing a purchaser arranges. Certificates of analysis differ widely in which tests they report and in the limits applied. The counter-ion introduced during purification, commonly acetate or trifluoroacetate, changes the net peptide content of a given mass of powder, so two samples of equal weight may not contain equal amounts of the active sequence. Third-party laboratories can verify purity, identity, residual solvents, and counter-ion content for a fee, which makes documentation more informative than labelling.

Verification of a sample usually begins with reversed-phase high-performance liquid chromatography, which resolves the peptide from truncated sequences and other impurities and expresses purity as a percentage of total peak area. Mass spectrometry by electrospray ionisation or matrix-assisted laser desorption supplies an independent check, because the measured mass can be compared against the theoretical value for AEDG. Amino acid analysis or tandem mass spectrometry sequencing can confirm residue order. Each of these methods answers a different question: a purity figure does not establish identity, and an identity match does not establish how much of the material is intact peptide.

Epitalon at a glance

PropertyValueNotes
Amino acid sequenceAla-Glu-Asp-GlyLinear tetrapeptide, also written AEDG
Molecular massAbout 390.35 g/molValue calculated from the sequence
AppearanceWhite to off-white powderLyophilised material forms a loose cake
SolubilityFreely soluble in waterAlso dissolves in isotonic saline
Storage-20 °C, desiccatedAliquot solutions to avoid freeze–thaw cycling

Epitalon Background and Nomenclature

The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.

Laboratory work has examined effects on telomerase activity in cultured cells, on melatonin rhythms in animals, and on markers of oxidative stress. Some experiments report measurable changes while others show none, and the reported findings rest largely on small studies. The absence of large independent trials means the generality of these results is unresolved rather than settled. Review articles occasionally apply the label geroprotector, a term that reflects a research hypothesis about ageing rather than an established clinical finding.

Related pages on this site

Analytical Characterization and Stability

Identity testing for epitalon relies on reversed-phase high-performance liquid chromatography for purity and mass spectrometry for mass confirmation. Because the sequence contains no tryptophan or tyrosine, ultraviolet detection at 280 nanometres is insensitive, so chromatographic methods usually monitor absorbance near 214 nanometres, where the peptide backbone absorbs. Electrospray ionisation or matrix-assisted laser desorption/ionisation then checks the intact mass against the expected value near 390 daltons. Peptide mapping or amino acid analysis after acid hydrolysis can supplement these measurements, although such confirmatory work is seldom reported on commercial certificates of analysis.

Stability of the tetrapeptide follows ordinary peptide chemistry rather than any unusual structural feature. The aspartate-glycine pair is prone to aspartimide formation under mildly basic or neutral conditions, and deamidation can follow, altering both mass and chromatographic retention. Dry lyophilised powder kept at or below minus twenty degrees Celsius is the usual handling recommendation, with repeated freeze-thaw cycles avoided. Once dissolved in neutral aqueous buffer, degradation proceeds over days to weeks depending on pH and temperature, while acidic conditions generally slow the aspartimide route. A formal stability-indicating study has not been published in the indexed literature.

Peptide Identity and Laboratory Handling

Laboratory-grade epitalon is typically supplied as a lyophilized powder. Purity is commonly assessed with reverse-phase high-performance liquid chromatography, often paired with mass spectrometry to confirm molecular identity. Amino acid analysis and peptide mapping can provide additional confirmation of sequence. Certificates of analysis for research materials frequently report purity above 95 percent, although the methods behind such figures vary between suppliers. The absence of a pharmacopeial monograph means that no single standardized assay defines the compound, so reported results depend on the analytical protocol chosen.

Storage recommendations center on limiting moisture, heat, and light. The dry powder is generally kept at minus 20 degrees Celsius, and some suppliers recommend minus 80 degrees for long-term archival. Once dissolved, solutions are usually aliquoted and frozen to avoid repeated freeze-thaw cycles, which can promote aggregation or degradation. Aqueous stability depends on pH and concentration, and buffered saline is often preferred over plain water for biological work. Stability data specific to epitalon remain limited, so general peptide-handling practices are applied by analogy rather than from product-specific validation.

Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and its calculated monoisotopic mass is approximately 390.35 daltons. The compound does not occur naturally as a free peptide; it is produced by solid-phase peptide synthesis. Because it contains two acidic residues and no basic residues, the neutral form carries a net negative charge at physiological pH. This charge profile influences how the peptide behaves in solution and during chromatographic analysis.

Stability Handling and Quality Control

Material sold for research use varies widely in documented quality. A useful verification package includes a certificate of analysis that states peptide content rather than only net weight, the chromatographic method and column used, and a mass spectrum consistent with the expected mass. Independent testing by a third-party laboratory is occasionally reported. Statements of identity resting only on a supplier label provide little assurance, and the gap between nominal mass and actual peptide content can be substantial once counterions and residual water are counted.

Peptides of this size are generally stable as dry solids but degrade in solution over time. The principal routes are hydrolysis of the peptide backbone and oxidation, with hydrolysis favoured by elevated temperature and extreme pH. Aqueous solutions held at room temperature can show measurable loss of purity within days, while frozen aliquots are considerably more durable. Because the sequence contains neither cysteine nor methionine, oxidation is less of a concern than for many other peptides, but pH control during handling still matters.

Typical storage for the lyophilized powder is −20 °C or lower, in a sealed container protected from light and moisture. Hygroscopic material should be allowed to equilibrate to room temperature before the vial is opened, which limits condensation on the contents. Working solutions are commonly divided into single-use aliquots and frozen to avoid repeated freeze-thaw cycles. Dilute solutions are more prone to adsorption onto plastic surfaces and to loss during filtration, so procedures that minimize transfers and use low-binding labware are preferable.

Supporting material

== Deficiency == Low values of HbA2, defined as 2.1% and below, can stem from various factors. The different reasons for reduced HbA2 levels depend on the factors such as hematological indices, hemoglobin patterns, red blood cells, and iron status. Reports suggest that individuals with low iron levels often exhibit low levels of HbA2. Additionally, low levels of HbA2 may be caused from decreased transcription or translation of the globin chains, which would affect how they bind.

=== Regulation of indoor VOC emissions === In most countries, a separate definition of VOCs is used with regard to indoor air quality that comprises each organic chemical compound that can be measured as follows: adsorption from air on Tenax TA, thermal desorption, gas chromatographic separation over a 100% nonpolar column (dimethylpolysiloxane). VOC (volatile organic compounds) are all compounds that appear in the gas chromatogram between and including n-hexane and n-hexadecane. Compounds appearing earlier are called VVOC (very volatile organic compounds); compounds appearing later are called SVOC (semi-volatile organic compounds). France, Germany (AgBB/DIBt), Belgium, Norway (TEK regulation) and Italy (CAM Edilizia) have enacted regulations to limit VOC emissions from commercial products. European industry has developed numerous voluntary ecolabels and rating systems, such as EMICODE, M1, Blue Angel, GuT (textile floor coverings), Nordic Swan Ecolabel, EU Ecolabel, and Indoor Air Comfort. In the United States, several standards exist; California Standard CDPH Section 01350 is the most common one. These regulations and standards changed the marketplace, leading to an increasing number of low-emitting products.

[we are] cleaning the affront of the traitors who broke their word and oaths and acted without hesitation against Masonic democracy." Sergio Rafael Vidal Águila stated that the decision was: "...not only an act of justice, but of restoration, because it was very difficult to accept those persons as deserving of membership… because of what it represents that they violated their oaths without shame and were part of what, without a doubt, was not only a collection of ambitions but the service of outdated men in the shadow of a political power that used them to persecute Freemasons within the Institution itself." The Court also affirmed that the actions of the protestors on June 5, 2025 were in their eyes a legitimate attempt to restore institutional order. The expulsions were submitted pending their ratification at the semi-annual meeting of the High Chamber of the Grand Lodge of Cuba, in September 2026.

Some of those changes are: a shortening of the membranous vocal fold in males, a thickening of the vocal fold mucosa and cover in females, and a development of edema in the superficial lamina propria layer in both sexes. Hammond et al. observed that the hyaluronic acid content in the vocal fold lamina propria was significantly higher in males than in females. Although all those studies did show that there are clear structural and functional changes seen in the human vocal cords which are associated with gender and age, none really fully elucidated the underlying cause of those changes. In fact, only a few recent studies started to look at the presence and role of hormone receptors in the vocal cords. Newman et al. found that hormone receptors are indeed present in the vocal cords, and show a statistical distribution difference with respect to age and gender. They have identified the presence of androgen, estrogen, and progesterone receptors in epithelial cells, granular cells and fibroblasts of the vocal cords, suggesting that some of the structural changes seen in the vocal cords could be due to hormonal influences. In this specific study, androgen and progesterone receptors were found more commonly in males than in females. In others studies, it has been suggested that the estrogen/androgen ratio be partly responsible for the voice changes observed at menopause. As previously said, Hammond et al. showed than the hyaluronic acid content was higher in male than in female vocal cords. Bentley et al.

== See also == Fleet telematics Fleet tracking GPS tracking National Association of Fleet Administrators (NAFA) Satellite tracking Telematics Vehicle remarketing Vehicle tracking system Fleet management software

Sources: en.wikipedia.org

Notes from published material

In September 1936, Fry's released an aerated Crunchie bar made entirely of chocolate. They justified this move as not breaching the patent, saying it was not a block but a bar. As Aero sales began to dip, Rowntree's brought out variants, selling the first aerated chocolates with fruit and nut inclusions. After Fry's launched a second aerated chocolate in August 1937 called Ripple, Rowntree's had to decide whether they wanted to try to enforce their patent. By this time, Nestlé and Fry's had joined Cadbury in having expressed a willingness to challenge the patent in the courts despite it being officially approved by the patent office. On legal advice that there was a 50% likelihood of success in a court challenge, and the threat of court proceedings causing bad publicity, Rowntree's entered negotiations with other chocolate makers to discuss licensing aerated chocolate. Rival companies were dominant in the proceedings dialogues, and Rowntree's ultimately agreed to licence aerated chocolate from June 1938 under the conditions that chocolate makers pay a sum with the release of new aerated chocolate lines and a 0.5% royalty on sales. After this agreement was put in place, Cadbury only released aerated chocolate products in overseas dominions where Aero was not established. Nestlé-produced aerated chocolates included a chocolate called Bubblo, made in the UK for export to New Zealand under a New Zealand patent. Aerated chocolate was already being sold in some overseas markets, by 1936 for instance, Aero was being successfully exported to Australia.

His only other appearance came in Game 6, when he pitched a scoreless fourth and fifth inning's in Pittsburgh's 12–0 defeat. Despite posting a 15.43 ERA, Mizell became a World Series champion for the only time in his career, as the Pirates clinched the series in Game 7 on Bill Mazeroski's game-ending home run. Entering the 1961 season, Sports Illustrated predicted that Mizell "may win more this year." Indeed, he got off to a 4–1 start, posting a 3.57 ERA through May 24. However, Mizell slumped in 1961. He lost seven straight decisions through the end of July, getting moved to the bullpen and only making two starts between June 15 and July 27. Used as a starter during the week of August 6–12, however, he won two games, the second of which was a five-hit shutout of the Phillies. It would be his only shutout of the year. Mizell started two more games that month but lost both and was used only twice in September, as a relief pitcher. In 25 games (17 starts), he had a 7–10 record, a 5.04 ERA, 37 strikeouts, and 31 walks in 100 innings pitched. Mizell was slightly late for spring training due to the birth of his second son in 1962. In his first start of the year, he defeated the expansion New York Mets, limiting them to one unearned run over seven innings. That was his only win through May 7, as he posted a 4.96 ERA in three games (three starts). On May 7, he was traded to the Mets for Jim Marshall, much to the chagrin of Pirates fans and players, with whom Mizell had been popular.

standard genetic code The genetic code used by the vast majority of living organisms for translating nucleic acid sequences into proteins. In this system, of the 64 possible permutations of three-letter codons that can be made from the four nucleotides, 61 code for one of the 20 amino acids, and the remaining three code for stop signals. For example, the codon CAG codes for the amino acid glutamine and the codon UAA is a stop codon. The standard genetic code is described as degenerate or redundant because some amino acids can be coded for by more than one different codon.

Carbon nanotubes are modelled in a similar manner as traditional composites in which a reinforcement phase is surrounded by a matrix phase. Idealized models such as cylindrical, hexagonal and square models are common. The size of the micromechanics model is a function of the studied mechanical properties. The concept of representative volume element (RVE) is used to determine the appropriate size and configuration of the computer model to replicate the actual behavior of the CNT-reinforced nanocomposite. Depending on the material property of interest (thermal, electrical, modulus, creep), one RVE might predict the property better than the alternatives. While the implementation of the ideal model is computationally efficient, they do not represent microstructural features observed in scanning electron microscopy of actual nanocomposites. To incorporate realistic modeling, computer models are also generated to incorporate variability such as waviness, orientation and agglomeration of multiwall or single-wall carbon nanotubes.

Sources: en.wikipedia.org

Further detail

=== Chromatographic separation === If the chromatographic separation can be modified to prevent coelution of suppressing species then other approaches need not be considered. The effect of chromatographic modification may be evaluated using the detector response monitoring under constant infusion approach described previously.

=== Biological === According to the National Institute of Health Curriculum Supplement Series book, most scientists believe that changes in neurotransmitters can cause mental illnesses. In the section "The Biology of Mental Illnesses" the issue is explained in detail, "...there may be disruptions in the neurotransmitters dopamine, glutamate, and norepinephrine in individuals who have schizophrenia".

The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services (HHS). The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, caffeine products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed, and veterinary products. The FDA's primary focus is enforcing the Federal Food, Drug, and Cosmetic Act (FD&C). However, the agency also enforces other laws, notably Section 361 of the Public Health Service Act as well as associated regulations. Much of this regulatory-enforcement work is not directly related to food or drugs but involves other regulated products like lasers, cellular phones, and condoms. In addition, the FDA uses its authority to mitigate diseases in a variety of contexts, from household pets to human sperm for use in assisted reproduction. The FDA is led by the commissioner of food and drugs, who is appointed by the president with the advice and consent of the Senate. The commissioner reports to the secretary of health and human services. Marty Makary is the current commissioner. The FDA's headquarters is located in the White Oak area of Silver Spring, Maryland, occupying the former Naval Ordnance Laboratory. The agency has 223 field offices and 13 laboratories located across the 50 states, the United States Virgin Islands, and Puerto Rico.

Sources: en.wikipedia.org

Frequently asked questions

Is epitalon a natural substance?

It is a synthetic tetrapeptide. Its sequence was derived from research on peptide fractions of bovine pineal extract, and the intact AEDG sequence has not been demonstrated as an abundant free peptide in human tissue.

What does the abbreviation AEDG mean?

AEDG is the one-letter code for the four amino acids alanine, glutamate, aspartate and glycine in that order. The same molecule is written in three-letter form as Ala-Glu-Asp-Gly.

How is the identity of epitalon confirmed in a laboratory?

Identity is normally confirmed by mass spectrometry against the calculated mass of roughly 390.35 g/mol. Purity is then estimated by reversed-phase high-performance liquid chromatography with ultraviolet detection.

Which method confirms epitalon identity?

Mass spectrometry provides the identity check, because the observed mass is compared with the theoretical mass of the AEDG sequence. Chromatography separates and quantifies impurities but does not by itself prove which peptide is present. The two techniques are normally used together.

Network